So I was searching online and I found this article about a company named ReNetX Bio that has just announced the initiation of a Series A financing round to fund its first clinical trial of its lead therapeutic candidate, Nogo Trap, in patients with chronic spinal cord injury. I personally think it's awesome that more people are doing or are planning do clinical trails for Chronic SCI.

Article: https://globenewswire.com/news-relea...niversity.html

Company Website: http://www.renetx.com/

Yale Discovery: http://ocr.yale.edu/news/yale-discov...al-cord-injury

Lab: http://strittmatter.medicine.yale.edu/